J. Goldman & CO LP Gilead Sciences, Inc. Put Options Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $586,160 - $664,720	-8,000 Reduced 22.86%	27,000 $2.19 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $2.59 Million - $2.82 Million	35,000 New	35,000 $2.62 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $5.66 Million - $6.46 Million	95,000 New	95,000 $5.86 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.